# New Neoplasm Metastasis trials, last 30 days: 28 (2026)

Updated November 19, 2026.

28 new trials for Neoplasm Metastasis were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New Neoplasm Metastasis clinical trials, last 30 days: 28 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/new/neoplasm-metastasis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946393 | Preoperative CA 19-9 and the Pattern and Timing of Recurrence After Pancreatoduodenectomy (Whipple Operation) for Pancreatic Cancer | Minia University | Observational | Not yet recruiting | Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946393) |
| November 18, 2026 | NCT07944235 | Preoperative and Postoperative Radiosurgery in Patients With Brain Metastases Undergoing Surgery | Fundacion Miguel Servet | Not applicable | Recruiting | Brain Neoplasms, Neoplasm Metastasis, Radiosurgery, Neoadjuvant Therapy, Radiotherapy Adjuvant, Surgery | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944235) |
| November 18, 2026 | NCT07944144 | A Phase I/II Study to Learn About the Safety and Effects of a New Medicine Called IPN60350 Alone or in Combination With Other Anticancer... | Ipsen | Phase 1/2 | Not yet recruiting | Neoplasms, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944144) |
| November 17, 2026 | NCT07942064 | Remote Exercise iNtErvention for Wellbeing (RENEW) Trial | University of British Columbia | Phase 2 | Not yet recruiting | Exercise Adherence (Primary), Depressive Symptoms (Secondary), Anxiety (Secondary), Presenteeism Secondary), Wellbeing... | 664 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942064) |
| November 17, 2026 | NCT07940881 | A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors | SystImmune Inc. | Phase 1 | Recruiting | Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, First in Human, Metastatic Solid... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940881) |
| November 16, 2026 | NCT07937423 | DYNAMIC Pilot Optimization Trial | H. Lee Moffitt Cancer Center and Research Institute | Not applicable | Not yet recruiting | Advanced Cancer, Metastatic Cancer, Cancer Survivorship | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937423) |
| November 13, 2026 | NCT07937137 | Liver Tumor Microenvironment Remodeling Promotes Hepatocellular Carcinoma Progression | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Observational | Not yet recruiting | Liver Cancer (Primary and Metastatic) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937137) |
| November 13, 2026 | NCT07935226 | Induction Trastuzumab Rezetecan Followed by Maintenance Dalpiciclib and Endocrine Therapy as First-line Treatment of HR+/HER2 Low mBC | Harbin Medical University | Phase 2 | Not yet recruiting | Breast Cancer (Locally Advanced or Metastatic), HR Positive/HER2 Low Breast Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935226) |
| November 12, 2026 | NCT07934316 | LIMA1 Immunohistochemistry and Depth of Invasion as Prognostic Biomarkers in Oral Squamous Cell Carcinoma | Turku University Hospital | Observational | Enrolling by invitation | Oral Squamous Cell Carcinoma (OSCC), OSCC | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934316) |
| November 12, 2026 | NCT07933952 | Liver Metastasis in Pancreatic Ductal Adenocarcinoma: Regulatory Mechanisms and Clinical Significance | Nanjing Medical University | Observational | Recruiting | PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Metastatic... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933952) |
| November 12, 2026 | NCT07933055 | Phase 1b/2 to Evaluate the Safety, Tolerability, and Efficacy of TXN10128 in Combination With TOPO-I Inhibitor-based Therapies (Irinotecan... | Txinno Bioscience Inc. | Phase 1/2 | Recruiting | NSCLC (Non-small Cell Lung Cancer) | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933055) |
| November 10, 2026 | NCT07928362 | A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of... | Ruijin Hospital | Not applicable | Not yet recruiting | Pancreatic Neoplasms, Neoplasm Metastasis | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928362) |
| November 10, 2026 | NCT07928167 | Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer Patients | Kidney Cancer Research Bureau | Phase 2 | Recruiting | Metastatic Renal Cell Carcinoma ( mRCC) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928167) |
| November 10, 2026 | NCT07928037 | A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic... | Novartis Pharmaceuticals | Observational | Not yet recruiting | Metastatic Castration-Resistant Prostate Cancer | 2,045 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928037) |
| November 5, 2026 | NCT07920198 | Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient... | Azienda Ospedaliero-Universitaria di Modena | Observational | Recruiting | Cushing s Syndrome, Cushing Disease, Cushing Disease Due to Increased ACTH Secretion, Mild Autonomous Cortisol... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920198) |
| November 5, 2026 | NCT07919834 | Ultrasonographic Tissue Thickness After Complex Decongestive Therapy in Lower-Limb Lymphedema | Kayseri City Hospital | Observational | Completed | Lymphedema of Lower Limb, Lymphedema, Secondary | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919834) |
| November 5, 2026 | NCT07918872 | Effect of Squatting Position in the Second Stage of Labor on Birth Outcomes | Ege University | Not applicable | Recruiting | Nulliparity, Labor Stage, Second, Birth Position, Squatting Position | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918872) |
| November 2, 2026 | NCT07909031 | CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Crescent Biopharma, Inc. | Phase 1/2 | Recruiting | Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)... | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909031) |
| October 29, 2026 | NCT07905313 | Study of Trastuzumab Deruxtecan in Combination With Stereotactic Radiosurgery in Patients With HER2-Positive Metastatic Breast Cancer and... | Azienda Ospedaliero-Universitaria Careggi | Phase 2 | Not yet recruiting | Breast Cancer (Advanced/Metastatic) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905313) |
| October 29, 2026 | NCT07904494 | Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular... | Assiut University | Observational | Not yet recruiting | Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular... | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904494) |
| October 29, 2026 | NCT07904013 | Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis | University Hospital, Bordeaux | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904013) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| October 29, 2026 | NCT07902544 | Station-Specific Lymph Node Metastasis After Neoadjuvant Chemoimmunotherapy for Middle Thoracic Esophageal Squamous Cell Carcinoma | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Observational | Completed | Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Metastasis | 717 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902544) |
| October 28, 2026 | NCT07901803 | Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma | Washington University School of Medicine | Phase 2 | Not yet recruiting | Head and Neck (HNSCC), Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Head and Neck... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901803) |
| October 28, 2026 | NCT07900984 | A Retrospective Registry of Intelliblate DUAL Channel Microwave Ablation | Varian, a Siemens Healthineers Company | Observational | Not yet recruiting | Liver Ablation, Liver Cancer, Liver Cancer (Primary and Metastatic) | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900984) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 3 |
| Phase 1/2 | 4 |
| Phase 2 | 5 |
| Not applicable | 4 |
| Observational | 12 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| Minia University | 1 |
| Fundacion Miguel Servet | 1 |
| [Ipsen](https://specstream.ai/data/clinical-trials/company/ipsen) | 1 |
| University of British Columbia | 1 |
| SystImmune Inc. | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 1 |
| Harbin Medical University | 1 |
| Turku University Hospital | 1 |
| Nanjing Medical University | 1 |
| Txinno Bioscience Inc. | 1 |
| Ruijin Hospital | 1 |
| Kidney Cancer Research Bureau | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| Azienda Ospedaliero-Universitaria di Modena | 1 |
| Kayseri City Hospital | 1 |
| Ege University | 1 |
| Crescent Biopharma, Inc. | 1 |
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| Assiut University | 1 |
| University Hospital, Bordeaux | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
| Washington University School of Medicine | 1 |
| [Varian, a Siemens Healthineers Company](https://specstream.ai/data/clinical-trials/company/varian-a-siemens-healthineers-company) | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cigar bars in the United States](https://specstream.ai/data/businesses/cigar-bars/united-states)
- [Dumpling restaurants in the United States](https://specstream.ai/data/businesses/dumpling-restaurants/united-states)
- [Food and beverage consultants in the United States](https://specstream.ai/data/businesses/food-and-beverage-consultants/united-states)
- [Hydro jetting companies in the United States](https://specstream.ai/data/businesses/hydro-jetting-companies/united-states)
- [Malaysian restaurants in the United States](https://specstream.ai/data/businesses/malaysian-restaurants/united-states)
- [Packing services in the United States](https://specstream.ai/data/businesses/packing-services/united-states)
